Literature DB >> 2153921

Control of retroviral RNA splicing through maintenance of suboptimal processing signals.

R A Katz1, A M Skalka.   

Abstract

The full-length retroviral transcript serves as genomic RNA for progeny virions, as an mRNA for structural proteins and enzymes, and as a pre-mRNA substrate for splicing that yields subgenomic mRNAs that encode other essential proteins. Thus, RNA splicing to form subgenomic mRNAs must be incomplete or regulated in order to preserve some of the full-length transcripts. We have used the avian sarcoma virus system to delineate the viral functions that are required in the regulation of the splicing event that forms the envelope glycoprotein (env) subgenomic mRNA. We observed previously that a specific insertion mutation just 5' of the env splice acceptor site resulted in nearly complete splicing to form env mRNA and a concomitant replication defect which is presumably due to a deficit of the full-length transcript. Replication-competent pseudorevertants contained second-site mutations that restored splicing control, and these mapped either just upstream or downstream of the env splice acceptor site. In this report, we show that splicing control at this site does not require expression of any known viral replication protein(s), nor does it appear to require the viral splice donor site. From these results and analysis of additional splicing mutations obtained by in vivo selection, we conclude that splicing is controlled through the maintenance of suboptimal cis-acting signals in the viral RNA that alter the efficiency of recognition by the cellular splicing machinery.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153921      PMCID: PMC360868          DOI: 10.1128/mcb.10.2.696-704.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect the accumulation of unspliced RNA.

Authors:  C M Stoltzfus; S J Fogarty
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

Review 2.  Regulation of HIV and HTLV gene expression.

Authors:  H Varmus
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

3.  The role of the mammalian branchpoint sequence in pre-mRNA splicing.

Authors:  R Reed; T Maniatis
Journal:  Genes Dev       Date:  1988-10       Impact factor: 11.361

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.

Authors:  S Goff; P Traktman; D Baltimore
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

6.  cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: implication for mechanisms of control.

Authors:  R A Katz; M Kotler; A M Skalka
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Transforming viruses spontaneously arise from nontransforming reticuloendotheliosis virus strain T-derived viruses as a result of increased accumulation of spliced viral RNA.

Authors:  C K Miller; J E Embretson; H M Temin
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

Review 8.  Synthesis and processing of avian sarcoma retrovirus RNA.

Authors:  C M Stoltzfus
Journal:  Adv Virus Res       Date:  1988       Impact factor: 9.937

9.  Regulation of Rous sarcoma virus RNA splicing and stability.

Authors:  S Arrigo; K Beemon
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

10.  Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm.

Authors:  P Legrain; M Rosbash
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

View more
  87 in total

1.  R region sequences in the long terminal repeat of a murine retrovirus specifically increase expression of unspliced RNAs.

Authors:  A M Trubetskoy; S A Okenquist; J Lenz
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  The role of overlapping U1 and U11 5' splice site sequences in a negative regulator of splicing.

Authors:  C S Hibbert; R R Gontarek; K L Beemon
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

3.  Retroviral splicing suppressor requires three nonconsensus uridines in a 5' splice site-like sequence.

Authors:  R E Paca; C S Hibbert; C T O'Sullivan; K L Beemon
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 4.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

5.  The mechanisms controlling ribosomal protein L1 pre-mRNA splicing are maintained in evolution and rely on conserved intron sequences.

Authors:  S Prislei; S Sperandio; P Fragapane; E Caffarelli; C Presutti; I Bozzoni
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

6.  Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.

Authors:  S Schwartz; M Campbell; G Nasioulas; J Harrison; B K Felber; G N Pavlakis
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  Two distant upstream regions containing cis-acting signals regulating splicing facilitate 3'-end processing of avian sarcoma virus RNA.

Authors:  J T Miller; C M Stoltzfus
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

8.  Identification of cis-acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes.

Authors:  M E Nemeroff; U Utans; A Krämer; R M Krug
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

9.  A secondary structure that contains the 5' and 3' splice sites suppresses splicing of duck hepatitis B virus pregenomic RNA.

Authors:  Daniel D Loeb; Amanda A Mack; Ru Tian
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.

Authors:  Z H Si; D Rauch; C M Stoltzfus
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.